Gabapentinoid Use by Self-Reported Indication and Level of Evidence

J Gen Intern Med. 2024 Jan;39(1):156-158. doi: 10.1007/s11606-023-08418-7. Epub 2023 Oct 4.

Authors

Alexander Chaitoff¹, Niteesh K Choudhry², Nancy Haff², Julie C Lauffenburger²

Affiliations

¹ Center for Healthcare Delivery Sciences, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA, USA. achaitoff@bwh.harvard.edu.
² Center for Healthcare Delivery Sciences, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA, USA.

No abstract available

Publication types

Letter

MeSH terms

Analgesics, Opioid*
Gabapentin / therapeutic use
Humans
Self Report

Substances

Gabapentin
Analgesics, Opioid

Grants and funding

K23 HL161480/HL/NHLBI NIH HHS/United States